Summaries for patients. Rivaroxaban in patients transitioned from vitamin K antagonist therapy
- PMID: 23778921
- DOI: 10.7326/0003-4819-158-12-201306180-00001
Summaries for patients. Rivaroxaban in patients transitioned from vitamin K antagonist therapy
Original report in
-
Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial.Ann Intern Med. 2013 Jun 18;158(12):861-8. doi: 10.7326/0003-4819-158-12-201306180-00003. Ann Intern Med. 2013. PMID: 23778903 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical